Product Information

DILANTIN 30 MG CAPSULE is a brand (anda) product labeled by Viatris Specialty LLC, priced at $1.4995 per EA under NDC 58151011801. Its NADAC has been published 87 times since Mar 19, 2025.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILANTIN 30 MG CAPSULE

Extended Phenytoin Sodium
$1.4995per EA

Strength

30 mg/1

NDC

58151011801

Classification

Brand (ANDA)

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PHENYTOIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA084349

FDA Approved

Before 1982

TE Code

AB

On Market Since

1/15/2025

Pharmacological Classes

Anti-epileptic Agent
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C8 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inducers
Cytochrome P450 3A Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for DILANTIN 30 MG CAPSULE has been published 87 times since Mar 19, 2025, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4995 per EA
All-time high$1.4995 (Nov 11, 2026)
All-time low$1.4249 (May 21, 2025)
52-week high$1.4995
52-week low$1.4258
Median price$1.4971
Average price$1.4635
Largest weekly change+5.0% (Jan 7, 2026)
Weeks tracked87
Tracking sinceMar 19, 2025

Price History

1W

0.0%

1M

+0.0%

3M

+0.1%

6M

+0.2%

1Y

+5.2%

3Y

N/A

5Y

N/A

All

+4.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Extended Phenytoin Sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DILANTIN 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DILANTIN 30 MG CAPSULE, manufactured by Viatris Specialty LLC, is $1.4995 per EA (NDC 58151011801), effective Nov 11, 2026.

How has the price of DILANTIN 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DILANTIN 30 MG CAPSULE has risen 4.9%. It has been tracked across 87 weekly CMS publications since Mar 19, 2025.

What are the highest and lowest recorded NADAC prices for DILANTIN 30 MG CAPSULE?

Since Mar 19, 2025, the NADAC for DILANTIN 30 MG CAPSULE has ranged from a low of $1.4249 (May 21, 2025) to a high of $1.4995 (Nov 11, 2026), with a median of $1.4971 per EA.

Are there cheaper alternatives to DILANTIN 30 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DILANTIN 30 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DILANTIN 30 MG CAPSULE?

DILANTIN 30 MG CAPSULE (NDC 58151011801) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand (anda) product.